Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 865146, 8 pages
http://dx.doi.org/10.1155/2015/865146
Clinical Study

Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus after Helicobacter pylori Eradication: A Multicenter Study

1Division of Gastroenterology, Department of Internal Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan
2Sato Hospital, Kurashiki, Japan
3Tokutomi Clinic, Iwakuni, Japan
4Watanabe Hospital, Kurashiki, Japan
5Division of Endoscopy and Ultrasound, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan
6Department of Gastroenterology and Metabolism, Graduate School of Biomedical Sciences, Hiroshima University, Japan
7Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan
8Department of General Medicine, Kawasaki Medical School, Kurashiki 701-0192, Japan
9Department of Pathology, Kawasaki Medical School, Kurashiki 701-0192, Japan

Received 19 December 2014; Revised 18 April 2015; Accepted 20 April 2015

Academic Editor: David Bernardo

Copyright © 2015 Tomoari Kamada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Marugame, T. Matsuda, K.-I. Kamo, K. Katanoda, W. Ajiki, and T. Sobue, “Cancer Incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries,” Japanese Journal of Clinical Oncology, vol. 37, no. 11, pp. 884–891, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Warren and B. J. Marshall, “Unidentified curved bacilli on gastric epithelium in active chronic gastritis,” The Lancet, vol. 321, no. 8336, pp. 1273–1275, 1983. View at Publisher · View at Google Scholar
  3. J. Q. Huang, S. Sridhar, Y. Chen, and R. H. Hunt, “Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer,” Gastroenterology, vol. 114, no. 6, pp. 1169–1179, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Nomura, G. N. Stemmermann, P.-H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser, “Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii,” The New England Journal of Medicine, vol. 325, no. 16, pp. 1132–1136, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Parsonnet, G. D. Friedman, D. P. Vandersteen et al., “Helicobacter pylori infection and the risk of gastric carcinoma,” The New England Journal of Medicine, vol. 325, no. 16, pp. 1127–1131, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Uemura, S. Okamoto, S. Yamamoto et al., “Helicobacter pylori infection and the development of gastric cancer,” The New England Journal of Medicine, vol. 345, no. 11, pp. 784–789, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, “Schistosomes, liver flukes and Helicobacter pylori,” in IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 61, pp. 1–241, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, France, 1994. View at Google Scholar
  8. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, “Biological agents. Volume 100 B. A review of human carcinogens,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 100, part B, pp. 1–441, 2012. View at Google Scholar
  9. K. Fukase, M. Kato, S. Kikuchi et al., “Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial,” The Lancet, vol. 372, no. 9636, pp. 392–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Asaka, M. Kato, S.-I. Takahashi et al., “Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition,” Helicobacter, vol. 15, no. 1, pp. 1–20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Kamada, J. Hata, K. Sugiu et al., “Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 9, pp. 1121–1126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Shiotani, N. Uedo, H. Iishi et al., “Re-expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia,” International Journal of Cancer, vol. 121, no. 6, pp. 1182–1189, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Shiotani, N. Uedo, H. Iishi et al., “Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication,” Digestion, vol. 78, no. 2-3, pp. 113–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Higuchi, T. Takeuchi, N. Uedo et al., “Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study,” Gastric Cancer, vol. 7, no. 8, 2014. View at Publisher · View at Google Scholar
  15. M. Takayama, S. Matsui, M. Kawasaki et al., “Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers,” World Journal of Gastroenterology, vol. 19, no. 34, pp. 5706–5712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. K. H. Song, Y. C. Lee, D.-M. Fan et al., “Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study,” Digestion, vol. 84, no. 3, pp. 221–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Haruma, M. Ito, S. Kido et al., “Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis,” Digestive Diseases and Sciences, vol. 47, no. 4, pp. 862–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Chen, K. Haruma, T. Kamada et al., “Factors that affect results of the 13C urea breath test in Japanese patients,” Helicobacter, vol. 5, no. 2, pp. 98–103, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. F. Dixon, R. M. Genta, J. H. Yardley, and P. Correa, “Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994,” The American Journal of Surgical Pathology, vol. 20, no. 10, pp. 1161–1181, 1996. View at Google Scholar
  20. M. Kusano, Y. Shimoyama, S. Sugimoto et al., “Development and evaluation of FSSG: frequency scale for the symptoms of GERD,” Journal of Gastroenterology, vol. 39, no. 9, pp. 888–891, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kusano, H. Hosaka, A. Kawada et al., “Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease,” Journal of Gastroenterology and Hepatology, vol. 27, no. 7, pp. 1187–1191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Hongo, H. Miwa, M. Kusano, and J-FAST Group, “Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors,” Journal of Gastroenterology and Hepatology, vol. 27, no. 5, pp. 913–918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Yoshihara, K. Sumii, K. Haruma et al., “Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects,” American Journal of Gastroenterology, vol. 93, no. 7, pp. 1090–1096, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Miki, M. Morita, M. Sasajima, R. Hoshina, E. Kanda, and Y. Urita, “Usefulness of gastric cancer screening using the serum pepsinogen test method,” The American Journal of Gastroenterology, vol. 98, no. 4, pp. 735–739, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kiyohira, M. Yoshihara, M. Ito, K. Haruma, S. Tanaka, and K. Chayama, “Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels,” Journal of Gastroenterology, vol. 38, no. 4, pp. 332–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Sugiyama, F. Maruta, T. Ikeno et al., “Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil,” Cancer Research, vol. 58, no. 10, pp. 2067–2069, 1998. View at Google Scholar · View at Scopus
  27. T. Watanabe, M. Tada, H. Nagi, S. Sasaki, and M. Nakao, “Helicobacter pylori infection induces gastric cancer in Mongolian gerbils,” Gastroenterology, vol. 115, no. 3, pp. 642–648, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kodama, K. Murakami, T. Okimoto et al., “Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication,” Journal of Gastroenterology, vol. 47, no. 4, pp. 394–403, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Kleine, S. Kluge, and B. M. Peskar, “Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats,” Digestive Diseases and Sciences, vol. 38, no. 8, pp. 1441–1449, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Naito, T. Yoshikawa, T. Tanigawa et al., “Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study,” Free Radical Biology and Medicine, vol. 18, no. 1, pp. 117–123, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Moayyedi, J. Deeks, N. J. Talley, B. Delaney, and D. Forman, “An update of the Cochrane systematic review of Helicobacter pylori radication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews,” The American Journal of Gastroenterology, vol. 98, no. 12, pp. 2621–2626, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Moayyedi, S. Soo, J. Deeks et al., “Eradication of Helicobacter pylori for non-ulcer dyspepsia,” Cochrane Database of Systematic Reviews, vol. 25, no. 1, Article ID CD002096, 2005. View at Google Scholar · View at Scopus
  33. B. Zhao, J. Zhao, W.-F. Cheng et al., “Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up,” Journal of Clinical Gastroenterology, vol. 48, no. 3, pp. 241–247, 2014. View at Publisher · View at Google Scholar · View at Scopus